Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1148026-99-6
1446282-37-6
96962-41-3
1714139-62-4
116604-42-3
1360716-36-4
1820581-42-7 | 3-tert-butyl 4-methyl (4S)-1,3-thiazolidine-3,4-dicarboxylate | AA00I0C3 | MFCD27578216
1820641-75-5 | N-Isopropyl-N-(3-nitrophenyl)methanesulfonamide | AA00I0K3 | MFCD28122686
1820684-58-9 | 3-Amino-5-bromo-4-(propylamino)benzonitrile | AA00I0R2 | MFCD26383430
1820734-90-4 | 2-[(3-Fluorophenyl)carbonyl]piperidine hydrochloride | AA00I109 | MFCD28122673
1823879-58-8 | 2-Aminopyrimidine-4-carboxamide | AA00I18J | MFCD01646121
1845698-62-5 | Ethyl 7-bromo-2-methyl-1-propyl-1,3-benzodiazole-5-carboxylate | AA00I1F2 | MFCD28962777
1865077-51-5 | 3-chloro-5-fluoro-N-methylbenzamide | AA00I1QU | MFCD29044142
1881331-22-1 | 1-(Benzenesulfonyl)-1H-indol-3-ol | AA00I2K9 | MFCD29044779
1936047-52-7 | 1-(1H-Pyrazolo[3,4-b]pyridin-1-yl)propan-2-one | AA00I2X4 | MFCD28404683
1951444-55-5 | 6-Chloro-3-(pyridin-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine-8-carboxylic acid HCl | AA00I391 | MFCD29764428
